Monocaprin Enhances Bioavailability of Fucoxanthin in Diabetic/Obese KK-A(y) Mice.

Nagata K, Takatani N, Beppu F, Abe A, Tominaga E, Fukuhara T, Ozeki M, Hosokawa M

Open source

DOI
10.3390/md20070446
Published
2022 Jul 7
Container
Marine drugs
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/md20070446,
  title = {Monocaprin Enhances Bioavailability of Fucoxanthin in Diabetic/Obese KK-A(y) Mice.},
  author = {Nagata K and Takatani N and Beppu F and Abe A and Tominaga E and Fukuhara T and Ozeki M and Hosokawa M},
  year = {2022},
  journal = {Marine drugs},
  doi = {10.3390/md20070446},
  url = {https://doi.org/10.3390/md20070446}
}

RIS

TY  - JOUR
TI  - Monocaprin Enhances Bioavailability of Fucoxanthin in Diabetic/Obese KK-A(y) Mice.
AU  - Nagata K
AU  - Takatani N
AU  - Beppu F
AU  - Abe A
AU  - Tominaga E
AU  - Fukuhara T
AU  - Ozeki M
AU  - Hosokawa M
PY  - 2022
JO  - Marine drugs
DO  - 10.3390/md20070446
UR  - https://doi.org/10.3390/md20070446
ER  - 

APA

K, N., N, T., F, B., A, A., E, T., T, F., M, O., & M, H. (2022). Monocaprin Enhances Bioavailability of Fucoxanthin in Diabetic/Obese KK-A(y) Mice.. Marine drugs. https://doi.org/10.3390/md20070446

Source records